SUPPLEMENTING BOARD REGULATION NO. 5, SERIES OF 1972 BY INCLUDING ALPHA-METHYLTHIOFENTANYL, PARA-FLUOROFENTANYL, BETA-HYDROXYFENTANYL, BETA-HYDROXY-3-METHYLFENTANYL, THIOFENTANY…

SECTION 1.       Pursuant to its powers under Section 36(a)
of Republic Act No. 6425, as amended, the Dangerous Drugs Board, having
found later evaluation that the following substances:

INTERNATIONAL NON-PROPRIETARY NAME ( INN)	CHEMICAL NAME	OTHER NAME
Alpha-methylthio-fentanyl	N-[1-[1 methyl-2-(2- thienyl)ethyl]-4-piperidyl propionanilide	NIH 10538 MCV 4583
Para-fluorofentanyl	4′-fluoro-N-(1-phenethyl- 4-piperedyl) propionanilide	NIH 10022 NIH 10491 MCV 4323
Beta-hydroxyfen- tanyl	N-[1-beta-hydroxyphene- tyl)-4-piperidyl] propionanilide	NIH 10506 MCV 4568
Beta-hydroxy-3- methylfentanyl	N-[1-beta-hydroxyphene- tyl)-3-methyl-4- piperidyl] propionanilide	Ohmefentanyl F7302 NIH 10551 OMF
Thiofentanyl	N-[1-[2-[2-thienyl)ethyl] -4 piperidyl] propionanilide	NIH 10505 MCV 4567
3-methylthiofen- tanyl	N-[3-methyl-1-[2-[2- thienyl) ethyl]-4-piperidyl] propionanilide	NIH 10546 MCV 4591

so-called “designer drugs,” have the capacity to produce dependence
and are likely to be so abused as to constitute a public health and
social problem, which finding is in agreement with the recommendation of
the Director General of the World Health Organization to the Secretary
General of the United Nations Organization, that said substances be
included in Schedules I and IV of the 1961 Convention on Narcotic Drugs,
pursuant to Article 3, paragraph 1, of the 1961 Single Convention on
Narcotic Drugs, as amended by the 1972 Protocol, hereby classifies as
Dangerous Drugs and further categorized as Prohibited Drugs, the above
substances as well as their salts, isomers (whether optical, position,
or geometric) which (a) exist within the specific chemical designations
by whatever official name, common name or usual name, chemical name or
brand name and (b) have the .same or similar psychologic and/or
physiologic effect as the parent drugs mentioned at above.

SECTION 2.       All compounds, mixtures, or preparations
containing these substances and their salts, isomers qualified in
Section 1 hereof are classified as Dangerous Drugs and further
categorized as Prohibited Drugs.

SECTION 3.       The production, manufacture, export and
import, trade prescribing, dispensing, possession or use of any of the
above drugs for whatever purpose, including medical, scientific research
and clinical trials therewith are hereby prohibited.

SECTION 4.       Any violation hereof shall be a ground for the institution of criminal proceedings in the proper court.

SECTION 5.       This Regulation supplements Board
Regulation No. 5, Series of 1972 and shall take effect fifteen (15) days
after the completion of its publication in a newspaper of general
circulation once a week for two (2) consecutive weeks.

Adopted: 19 April 1990

(SGD.) TOMAS P. MARAMBA, JR., MD., MHA.
Vice-Chairman
(Undersecretary of Health for Standards and Regulation)